Long-Term Benefits of Nevirapine-Containing Regimens: Multicenter Study with 506 Patients, Followed-Up a Median of 9 Years
Author(s) -
Daniel Podzamczer,
Juan Tiraboschi,
Josep Mallolas,
Jordi Curto,
Miguel Ángel Cárdenes,
E Casas,
AC Castro,
S Echevarrı́a,
María Paula Rojas Leal,
J. C. Lopez Bernaldo de Quiros,
Santiago Moreno,
Teresa Puig,
Esteban Ribera,
C Villalonga,
J. L. Gómez-Sirvent,
José Antonio Garcia-Henarejos,
José López-Aldeguer,
Pilar Barrufet,
Lluís Force,
Ignacio de los Santos,
José Sanz
Publication year - 2012
Publication title -
current hiv research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.561
H-Index - 52
eISSN - 1873-4251
pISSN - 1570-162X
DOI - 10.2174/157016212802429820
Subject(s) - medicine , nevirapine , tolerability , regimen , gastroenterology , coinfection , retrospective cohort study , viral load , surgery , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , adverse effect
To evaluate long-term outcomes in patients maintaining a nevirapine (NVP)-based regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom